|
|
|
|
|
|
|
|
|
|
Clinical Endocrinology News
FROM THE JOURNAL OF CLINICAL ONCOLOGY
Vitals
Key clinical point: Oral contraceptive (OC) use was inversely associated with the risk of several types of ovarian cancer.
Major finding: Use of OCs was associated with
a 16% decrease in the risk of any type of ovarian cancer (relative
risk, 0.84; 95% confidence interval, 0.79-0.89).
Data source: A meta-analysis of 21 prospective studies that included 5,584 invasive ovarian cancer cases from more than 1.3 million women.
Disclosures: Dr. Wentzensen reported having
no financial disclosures. Other researchers reported financial
relationships with GlaxoSmithKline and Cepheid.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.